Nausea is most common during dose initiation, typically peaking 48-72 hours after injection
Omega-3 fatty acids from fish oil may enhance muscle protein synthesis response to amino acids
This multi-receptor engagement makes Retatrutide relevant to in vitro studies examining weight loss and weight reduction mechanisms, type 2 diabetes pathophysiology, and coordinated metabolic signaling
RELATED: Trump says GLP-1 weight-loss drugs coming at $50 for Medicare patients The Trump administration had said that coverage of the drugs for obesity will expand to Medicare patients starting next year, but Trump announced May 2 that Zepbound and Wegovy would be available to Medicare patients for $50 a month starting July 1
Results at 72 weeks were striking: 5mg dose: 15.0% average weight loss 10mg dose: 19.5% average weight loss 15mg dose: 20.9% average weight loss Placebo: 3.1% average weight loss At the highest dose, 36.2% of participants lost 25% or more of their body weight
Theres no official list of retatrutide side effects yet, because it isnt approved